Easton Pharmaceuticals, Inc. (EAPH)

Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica SA de C.V. and together, own the exclusive distribution rights in Mexico and Latin America for patented women’s diagnostic and preventative care products from Common Sense Of Israel and other companies, along with two generic cancer drugs, Paclitaxel and Docetaxel from BioLyse Pharma of St. Catherine’s Ontario, Canada. Easton has recently acquired 100% of iBliss Inc., a revenue generating company in the lucrative e-vaporizing market, with its own manufacturing facility in Canada supplying the local market as well as the United States and several European markets and Russia.

Committed to Providing Safe and Effective Products

Strategic Partnerships Collaborating and developing alliances with strategic partners around the world. Learn More

Social Responsibility Easton is dedicated to woman’s health, diagnostic, treatment and preventative care products Learn More

Creating Value Our goal is to create value for our shareholders through growth and innovation. Learn More

Innovative Products Easton products focus on the areas of women’s health and emerging cannabis markets. Learn More

LATEST EAPH PRESS RELEASES:

Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses

Easton Pharmaceuticals Aug 10, 2017 9:00 am

Easton Pharmaceuticals Announces Finalized Sub-Distribution Agreement With Gedeon Richter S.A.P.I de C.V. For Product Launch Of AmnioSense (AL-Sense)

Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman’s Diagnostics and Treatment Segment

 

 

For more information please visit OTC Markets

Get Social With Easton Pharmaceuticals

Follow on Twitter
Like on Facebook
Follow on Instagram
Subscribe on Youtube
Connect on Linkdin